{"nctId":"NCT01723696","briefTitle":"Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function","startDateStruct":{"date":"2012-12"},"conditions":["Pulmonary Function; Newborn, Abnormal","Infant Wheeze","In-utero Nicotine","Second Hand Smoke"],"count":252,"armGroups":[{"label":"placebo tablet+prenatal vitamin","type":"PLACEBO_COMPARATOR","interventionNames":["Dietary Supplement: Placebo tablet+prenatal vitamin"]},{"label":"Vitamin C +prenatal vitamin","type":"ACTIVE_COMPARATOR","interventionNames":["Dietary Supplement: Vitamin C +prenatal vitamin"]}],"interventions":[{"name":"Vitamin C +prenatal vitamin","otherNames":["Ascorbic acid"]},{"name":"Placebo tablet+prenatal vitamin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria: At randomization:\n\n* Singleton gestation\n* ≥ 15 years old\n* Gestational age between 13 and 22 weeks\n* Receiving prenatal care\n* Current smoker\n* English speaking\n\nExclusion Criteria:\n\n* Gestational age ≥ 23 and 0/7 weeks\n* Multiple gestation\n* Major fetal congenital anomalies\n* Current use of illicit drugs\n* Current alcohol abuse\n* Use of vitamin C (≥ 500 mg/day)\\>3 days per week since last menstrual period\n* Refusal to abstain from vitamin or supplements containing significant vitamin C other than those provided through or approved by study staff\n* History of kidney stone in patient\n* Insulin dependent diabetes\n* Complex maternal medical conditions\n* Participation in other conflicting research projects\n* Unable to demonstrate stable method of communication\n* Pregnancy by in-vitro fertilization\n* Plan to terminate pregnancy\n* Failure of medication compliance trial\n* Failure to return in designated period during placebo run-in\n* Body mass index \\> 50 at screening","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"15 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Forced Expiratory Flow at 75% of Expired Volume (FEF75)","description":"The primary outcome was the comparison of infant FEFs at 3 months of age obtained using the raised volume rapid thoracic compression (RVRTC) technique in offspring of pregnant smokers randomized to vitamin C versus placebo. The specific primary outcome parameter was the measurement of FEF at 75% of the expired volume (FEF75)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"188.7","spread":"66.4"},{"groupId":"OG001","value":"200.7","spread":"71.1"}]}]}]},{"type":"SECONDARY","title":"Forced Expiratory Flow at 75% of Expired Volume (FEF75)","description":"The measurement of forced expiratory flows and specifically FEF75 will be done at 12 months of age in infants born to pregnant smoking women randomized to vitamin C versus placebo during pregnancy. FEF75 will be measured with the raised volume rapid thoracic compression technique.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"324","spread":"84.1"},{"groupId":"OG001","value":"351.6","spread":"71.1"}]}]}]},{"type":"SECONDARY","title":"Incidence of Wheezing Through 12 Months of Age","description":"The incidence of wheezing through 12 months of age will be compared in the infants delivered to smoking pregnant women who were randomized to vitamin C (500 mg) versus placebo during pregnancy.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"63","spread":null},{"groupId":"OG001","value":"51","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":30,"n":126},"commonTop":["Upper respiratory tract infection","Gestational diabetes","Urinary tract infection","Vulvovaginal mycotic infection","Vaginitis bacterial"]}}}